Form 4: Saba Capital Management Reduces Stake in BlackRock Capital Allocation Term Trust

Saba Capital Management reports a decrease in its holdings of BlackRock Capital Allocation Term Trust (BCAT) shares.

Summary

• On February 12, 2025, Saba Capital Management sold 109,365 shares of BlackRock Capital Allocation Term Trust (BCAT) at a price of $15.69 per share.
• Following the transaction, Saba Capital Management's indirect beneficial ownership in BCAT is 12,959,606 shares.
• Boaz Weinstein, also associated with Saba Capital Management, is listed as a reporting person.
• The filing indicates that Saba Capital Management is a 10% owner and has a director relationship with the issuer.

Sentiment

Score: 5

Explanation: Neutral sentiment as it simply reports a transaction. The reduction in stake could be interpreted negatively, but without further context, it's a routine disclosure.

Negatives

• Saba Capital Management reduced its stake in BlackRock Capital Allocation Term Trust.

Industry Context

This filing reflects changes in ownership of a publicly traded closed-end fund. Such filings are common and provide transparency into the investment activities of major shareholders.

Stakeholder Impact

• Shareholders may react to the news of Saba Capital Management reducing its stake, potentially impacting the stock price.

Key Dates

Keywords

BlackRock Capital Allocation Term Trust, BCAT, Saba Capital Management, share disposal, Form 4, beneficial ownership, Boaz Weinstein